Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House panel chief demands accountability from US FDA on J&J plant bumbles

This article was originally published in Scrip

Executive Summary

Following through on his pledge to make the US FDA his main target for investigations and "hundreds" of hearings, Representative Darrel Issa (Republican-California), chairman of the US House Oversight and Government Reform Committee, again demanded accountability from the agency, this time for its failure to oversee a Puerto Rican plant at the center of numerous recalls of defective drugs made by Johnson & Johnson's McNeil Consumer Healthcare division.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC013044

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel